Two UMSOP Faculty Members Receive APhA Awards
April 8, 2024
Cherokee Layson-Wolf is a professor of practice, sciences, and health outcomes research, and James Polli is a professor of pharmaceutical sciences.
April 8, 2024
Cherokee Layson-Wolf is a professor of practice, sciences, and health outcomes research, and James Polli is a professor of pharmaceutical sciences.
December 20, 2023
James Polli, PhD, leads multiple intercampus research centers in regulatory science and drug quality.
September 9, 2022
James Polli leads two centers and an academic program at UMSOP.
January 1, 2022
New center strives to help develop generics and patients who need them
December 17, 2021
TOPRA Awards for Regulatory Excellence recognize high achievements in regulatory affairs community
November 30, 2021
Adjustments on detection method, type of trial should make it easier to gain approval of generic injectable iron drugs.
January 19, 2021
Second-year student pharmacists awarded first place in contest that aims to promote student interest in the field of regulatory science.
September 29, 2020
New center established by the School of Pharmacy, in collaboration with the University of Michigan, will increase access to safe and effective generic drugs through collaborative research, training, and exchange.
March 23, 2020
Team of second-year student pharmacists awarded first place in contest that aims to promote student interest in the field of regulatory science.
June 13, 2019
Event sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation addressed current knowledge gaps in the dissolution similarity evaluation of pharmaceutical products.
February 21, 2019
Third-year student pharmacists take the gold for their proposal to establish regulatory standards that protect patient privacy for individuals using wearable and implantable medical technologies.
October 3, 2018
Latest renewal allows for up to $5 million per year over five years, and will help M-CERSI further advance its mission to promote the development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.